Matt Stuckert Joins Lineus Medical Board of Directors
PrAtlas/22762526

FAYETTEVILLE, Ark. - PrAtlas -- Lineus Medical is pleased to announce the appointment of Matt Stuckert to its Board of Directors. Stuckert was previously a member of the Lineus Technical Advisory Board.  Stuckert brings over a decade of sales leadership experience in the vascular access space, and has held key roles at Magnolia Medical, Becton Dickinson, CareFusion, Cardinal Health, Enturia, and Venetec.. Throughout his career, he has successfully built and led sales teams, and has driven commercial growth, particularly in the adoption of novel new vascular technologies.

His expertise in sales strategy and business development will be instrumental in guiding Lineus Medical's continued success. With a deep understanding of the vascular access market, Stuckert's knowledge will help support the growth of the company's flagship product, SafeBreak Vascular. Stuckert commented, "I am excited to join Lineus Medical's Board of Directors and contribute to the company's growth. SafeBreak Vascular is a game-changing vascular access device that directly addresses IV complications and improves patient experience, both critical issues in hospitals. I look forward to leveraging my experience to help expand SafeBreak's adoption and support the company's mission of improving IV care."

More on PrAtlas

• Clinical Endpoints Successfully Met in Study for Groundbreaking 12-Lead ECG Synthesis Technology Allowing Software Application to FDA: HeartBeam, Inc
• Boston Industrial Solutions, Inc. Unveils Natron® 504N UV LED Inks Designed for EPSON Printheads
• Kavelle Christie: Trump's First 100 Days Mark Alarming Breakdown in Healthcare, Public Health, and Freedoms
• OpenSSL Technical Advisory Committee Elections Now Open – Cast Your Vote
• Axiros Confirms Continued Compliance with ISO/IEC 27001:2022 After Surveillance Audit

Vance Clement, CEO of Lineus Medical said, "Matt Stuckert's extensive experience in vascular access sales and marketing makes him a valuable addition to our Board. His insights will be instrumental as we expand SafeBreak Vascular's presence in hospitals nationwide. We are excited to have him join our board as we continue to revolutionize what vascular access care looks like."

SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications¹. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money.¹

About Lineus Medical

Lineus Medical is the developer of break-away technology proven to reduce IV restarts and complications¹. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.

References:
1. Data on File